-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Cyclerion Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
- Cyclerion Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $138K, a 13.2% decline year-over-year.
- Cyclerion Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $606K, a 71% decline year-over-year.
- Cyclerion Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.07M, a 82.9% decline from 2022.
- Cyclerion Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.25M, a 35% decline from 2021.
- Cyclerion Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $9.61M, a 35.9% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)